Nobivac KC nosies lašai, liofilizatas ir skiediklis suspensijai ruošti šunims
Nobivac KC nosies lašai, liofilizatas ir skiediklis suspensijai ruošti šunims
Authorised
- Canine parainfluenza virus, strain Cornell, Live
- Bordetella bronchiseptica, strain B-C2, Live
Product identification
Medicine name:
Nobivac KC nosies lašai, liofilizatas ir skiediklis suspensijai ruošti šunims
Active substance:
- Canine parainfluenza virus, strain Cornell, Live
- Bordetella bronchiseptica, strain B-C2, Live
Target species:
-
Dog
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Canine parainfluenza virus, strain Cornell, Live630957.00/tissue culture infective dose 500.40millilitre(s)
-
Bordetella bronchiseptica, strain B-C2, Live501187.00/Colony forming unit0.40millilitre(s)
Pharmaceutical form:
-
Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
-
Nasal use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AF
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/02/1479/001-002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1479.pdf
Lithuanian (PDF)
Download Published on: 22/06/2022
Updated on: 23/06/2022
How useful was this page?:
